Evidence map›Paper›PMID 29040416›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2017

Fractionating the Neurocognitive Mechanisms Underlying Working Memory: Independent Effects of Dopamine and Parkinson's Disease.

Sean James Fallon, Rozemarijn Margaretha Mattiesing, Kinan Muhammed, Sanjay Manohar, Masud Husain

Open access · hybridAbstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 45 citations in OpenAlex.

  1. Methylphenidate undermines or enhances divergent creativity depending on baseline dopamine synthesis capacity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  2. Article
  3. Article
  4. Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Dopamine effects on memory load and distraction during visuospatial working memory in cognitively normal Parkinson's disease.Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Ignoring versus updating in working memory reveal differential roles of attention and feature binding.Cortex; a journal devoted to the study of the nervous system and behavior · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sean James FallonDepartment of Experimental Psychology, University of Oxford, New Radcliffe House, Walton Street, Oxford, OX2 6AG, UK.
Rozemarijn Margaretha MattiesingDepartment of Experimental Psychology, University of Oxford, New Radcliffe House, Walton Street, Oxford, OX2 6AG, UK.
Kinan MuhammedDepartment of Experimental Psychology, University of Oxford, New Radcliffe House, Walton Street, Oxford, OX2 6AG, UK.
Sanjay ManoharDepartment of Experimental Psychology, University of Oxford, New Radcliffe House, Walton Street, Oxford, OX2 6AG, UK.
Masud HusainDepartment of Experimental Psychology, University of Oxford, New Radcliffe House, Walton Street, Oxford, OX2 6AG, UK.
University of Oxford · GB

Funding

Medical Research Council MR/P00878X/1Wellcome Trust 098282
6 · The paper itself

Abstract

Deficits in working memory (WM) in Parkinson's disease (PD) are often considered to be secondary to dopaminergic depletion. However, the neurocognitive mechanisms by which dopamine causes these deficits remain highly contested, and PD is now also known to be associated with nondopaminergic pathology. Here, we examined how PD and dopaminergic medication modulate three components of WM: maintenance over time, updating contents with new information and making memories distracter-resistant. Compared with controls, patients were disproportionately impaired when retaining information for longer durations. By applying a probabilistic model, we were able to reveal that the source of this error was selectively due to precision of memory representations degrading over time. By contrast, replenishing dopamine levels in PD improved executive control over both the ability to ignore and update, but did not affect maintenance of information across time. This was due to a decrease in guess responses, consistent with the view that dopamine serves to prevent WM representations being corrupted by irrelevant information, but has no impact on information decay. Cumulatively, these results reveal a dissociation in the neural mechanisms underlying poor WM: whereas dopamine reduces interference, nondopaminergic systems in PD appear to modulate processes that prevent information decaying more quickly over time.

Indexed as

Memory DisordersAgedAntiparkinson AgentsAttentionDopamineDopamine AgentsExecutive FunctionFemaleHumansMaleMemory, Short-TermMental RecallModels, NeurologicalModels, StatisticalNeuropsychological TestsParkinson DiseaseAntiparkinson AgentsDopamineDopamine AgentsCognitive controldopamineParkinson’s diseaseworking memory

Identifiers

PMID29040416
PMCPMC5939219
OpenAlexW2762751960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.